Nifty

:

22620.40

Sensex

:

73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22620.40
73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

57/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

343.55

26-Apr-2024

Open
High
Low
Previous Close

332.00
346.00
330.35
333.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

80320
272.98
514.85
273.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

913.56
36.16
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

801.96
1.45%
4.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.11
7.25
7.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.33
29.60
12.35

PAT CAGR (%)

10 Years
5 Years
3 Years

28.84
29.92
16.13

P:E (Median)

8 Years
5 Years
3 Years

18.80
20.80
35.45

P:BV (Average)

8 Years
5 Years
3 Years

4.37
4.37
5.63

EV:EBITDA (Average)

8 Years
5 Years
3 Years

277.97
15.72
22.20

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 47.23 60.14 -21.47% 57.83 60.53 -4.46% 60.15 60.60 -0.74% 55.45 52.14 6.35%
Expenses 43.84 51.51 -14.89% 49.46 47.63 3.84% 51.52 54.18 -4.91% 50.01 51.51 -2.91%
EBITDA 3.40 8.63 -60.60% 8.36 12.90 -35.19% 8.64 6.42 34.58% 5.44 0.63 763.49%
EBIDTM 7.19% 14.36% 14.47% 21.31% 14.36% 10.59% 9.81% 1.20%
Other Income 2.52 1.74 44.83% 2.27 1.12 102.68% 2.00 0.31 545.16% 2.56 0.28 814.29%
Interest 0.23 0.18 27.78% 0.22 0.03 633.33% 0.15 0.01 1,400.00% 0.20 0.06 233.33%
Depreciation 0.41 0.33 24.24% 0.45 0.20 125.00% 0.39 0.19 105.26% 0.48 0.65 -26.15%
PBT 5.28 9.87 -46.50% 9.96 13.79 -27.77% 10.09 0.72 1,301.39% 7.32 0.20 3,560.00%
Tax 1.32 2.08 -36.54% 2.49 3.38 -26.33% 2.61 0.35 645.71% 1.72 0.18 855.56%
PAT 3.96 7.78 -49.10% 7.47 10.41 -28.24% 7.48 0.37 1,921.62% 5.60 0.02 27,900.00%
PATM 8.39% 12.94% 12.92% 17.20% 12.43% 0.61% 10.10% 0.05%
EPS 1.50 2.95 -49.15% 2.83 3.94 -28.17% 2.83 0.14 1,921.43% 2.12 0.01 21,100.00%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 220.66 236.71 217.58 187.95 158.57 166.83 126.53 143.87 143.49 138.15 143.85 Net Sales Growth -5.46% 8.79% 15.76% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% Cost Of Goods Sold 85.44 93.10 88.96 80.78 56.19 72.85 61.11 58.95 59.13 68.68 64.71 Gross Profit 135.22 143.61 128.62 107.17 102.38 93.98 65.42 84.92 84.36 69.47 79.14 GP Margin 61.28% 60.67% 59.11% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% Total Expenditure 194.83 202.56 192.56 168.87 150.04 157.49 137.64 138.10 131.68 129.42 133.17 Power & Fuel Cost - 0.29 0.47 0.52 0.76 1.41 1.00 2.12 2.26 1.77 2.23 % Of Sales - 0.12% 0.22% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% Employee Cost - 65.18 57.67 53.98 50.37 46.61 41.88 40.95 37.84 32.11 37.83 % Of Sales - 27.54% 26.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% Manufacturing Exp. - 0.52 1.05 0.62 0.51 0.73 0.96 1.34 1.70 1.01 1.57 % Of Sales - 0.22% 0.48% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% General & Admin Exp. - 22.29 28.47 18.75 23.55 19.03 16.31 16.44 13.61 9.64 8.55 % Of Sales - 9.42% 13.08% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% Selling & Distn. Exp. - 18.61 13.88 12.99 17.45 13.20 11.25 13.74 12.96 11.53 14.36 % Of Sales - 7.86% 6.38% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% Miscellaneous Exp. - 2.57 2.05 1.22 1.20 3.66 5.14 4.56 4.19 4.67 14.36 % Of Sales - 1.09% 0.94% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% EBITDA 25.84 34.15 25.02 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 EBITDA Margin 11.71% 14.43% 11.50% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% Other Income 9.35 5.73 3.43 4.39 2.53 1.43 0.46 0.47 0.66 0.11 0.06 Interest 0.80 0.41 0.28 0.51 0.51 0.75 0.66 2.64 5.30 4.46 5.38 Depreciation 1.73 1.21 1.53 1.09 1.13 1.02 0.32 1.99 3.09 2.71 2.83 PBT 32.65 38.27 26.64 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 Tax 8.14 8.09 7.79 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 Tax Rate 24.93% 23.24% 29.24% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% PAT 24.51 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 PAT before Minority Interest 24.51 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.11% 11.29% 8.67% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% PAT Growth 31.92% 41.68% 10.55% 116.77% 9.00% - - 264.92% 177.78% -44.81% EPS 9.28 10.12 7.14 6.46 2.98 2.73 -4.38 4.49 1.23 0.44 0.80

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 158.89 132.76 121.93 111.03 104.47 98.05 109.91 98.36 95.43 98.59 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 137.03 119.66 108.83 97.93 91.37 84.95 96.81 85.27 82.33 85.49 Non-Current Liabilities 8.48 4.49 1.88 3.09 3.12 3.19 3.26 3.61 3.60 4.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.07 1.26 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 35.18 34.14 40.40 34.57 28.19 28.58 29.44 57.31 55.19 53.58 Trade Payables 16.36 18.55 18.05 11.71 11.86 9.09 8.98 9.73 7.87 5.08 Other Current Liabilities 10.81 7.70 10.89 8.16 5.60 6.10 7.12 6.61 6.24 5.48 Short Term Borrowings 0.00 0.00 6.79 6.40 3.79 8.30 7.93 38.49 39.31 35.96 Short Term Provisions 8.01 7.89 4.67 8.30 6.95 5.09 5.41 2.48 1.77 7.06 Total Liabilities 202.55 171.39 164.21 148.69 135.78 129.82 142.61 159.28 154.22 156.25 Net Block 24.28 22.60 25.72 24.44 21.64 21.32 21.59 51.61 51.96 56.41 Gross Block 33.25 58.13 60.12 58.17 55.00 53.66 52.88 90.35 87.61 87.01 Accumulated Depreciation 11.75 35.53 34.40 33.74 33.36 32.34 31.28 38.74 35.65 30.60 Non Current Assets 30.39 55.14 43.73 52.39 38.23 35.20 32.50 58.32 58.43 64.94 Capital Work in Progress 0.00 0.00 0.00 1.90 3.95 3.04 0.00 0.00 0.00 2.35 Non Current Investment 1.12 28.86 12.06 11.39 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.69 1.07 5.66 14.53 12.63 10.84 10.90 6.71 6.47 6.19 Other Non Current Assets 4.29 2.62 0.29 0.13 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 172.17 116.25 120.48 96.31 97.56 94.61 110.11 100.96 95.79 91.31 Current Investments 0.00 21.81 3.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 20.68 29.74 29.72 29.32 32.69 51.43 47.62 39.84 33.06 30.59 Sundry Debtors 20.87 15.58 12.66 21.45 20.75 25.15 39.41 41.69 44.89 45.22 Cash & Bank 114.63 25.25 60.23 40.49 38.53 14.51 20.06 15.53 15.02 12.60 Other Current Assets 16.00 1.41 0.27 0.52 5.58 3.51 3.03 3.90 2.83 2.90 Short Term Loans & Adv. 14.85 22.47 14.34 4.52 4.64 3.27 2.80 3.90 2.83 2.90 Net Current Assets 136.99 82.11 80.08 61.74 69.37 66.03 80.68 43.65 40.60 37.73 Total Assets 202.56 171.39 164.21 148.70 135.79 129.81 142.61 159.28 154.22 156.25

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 46.66 6.91 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 7.52 PBT 34.81 26.64 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 Adjustment 9.25 -1.40 -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 8.15 Changes in Working Capital 9.88 -11.46 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 -2.65 Cash after chg. in Working capital 53.93 13.79 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 8.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.28 -6.87 -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -57.67 -25.78 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 Net Fixed Assets 24.88 1.99 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 -1.28 Net Investments 49.55 -35.36 -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 0.00 Others -132.10 7.59 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 0.07 Cash from Financing Activity -0.46 -17.55 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 Net Cash Inflow / Outflow -11.47 -36.42 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 2.26 Opening Cash & Equivalents 22.53 58.94 39.81 40.82 14.51 20.06 15.53 15.02 12.60 10.34 Closing Cash & Equivalent 11.05 22.53 58.94 39.81 38.53 14.51 20.06 15.53 15.02 12.60

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 57.30 50.68 43.55 39.39 36.89 34.43 38.96 34.55 33.43 32.86 ROA 14.29% 11.24% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% ROE 18.89% 15.28% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% ROCE 24.15% 21.23% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% Fixed Asset Turnover 5.63 4.10 3.18 2.80 3.07 2.38 2.03 1.62 1.59 1.68 Receivable days 25.87 21.26 33.13 48.57 50.22 93.07 102.03 109.58 118.23 109.72 Inventory Days 35.78 44.76 57.34 71.38 92.03 142.78 110.02 92.27 83.52 76.13 Payable days 68.44 75.08 67.24 34.46 31.91 27.07 22.17 21.36 15.26 9.95 Cash Conversion Cycle -6.79 -9.07 23.23 85.49 110.33 208.78 189.88 180.49 186.49 175.90 Total Debt/Equity 0.00 0.00 0.06 0.06 0.04 0.09 0.08 0.43 0.45 0.42 Interest Cover 85.28 94.48 43.59 19.31 13.08 -16.69 6.44 1.77 1.37 1.47

Top Investors:

mukul mahavir agrawal

authum investment and infrastructure limited

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharmaceuticals launches ‘QueeZy-ER’
9th Mar 2024, 14:45 PM

The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
Read More
Jagsonpal Pharmaceutical launches QueeZy-ER
8th Mar 2024, 16:54 PM

Queezy-ER is now available in leading pharmacies across India
Read More
Jagsonpal Pharma - Quarterly Results
2nd Feb 2024, 17:24 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback